title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
uniQure Announces Update on U.S. Phase I/II Clinical Trial of AMT-130 Gene Therapy for the Treatment of Huntington's Disease,20230621T110500,https://www.globenewswire.com/news-release/2023/06/21/2691872/0/en/uniQure-Announces-Update-on-U-S-Phase-I-II-Clinical-Trial-of-AMT-130-Gene-Therapy-for-the-Treatment-of-Huntington-s-Disease.html,TTBLF,0.016216,Neutral,0.08808
